Mechanism of action
Tisotumab vedotin-tftv is a tissue factor (TF)-directed antibody drug conjugate (ADC).
General use cases
- Uterine Cervical Neoplasms
- adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
